Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC

Diabetic patients treated with metformin have a reduced incidence of cancer and cancer-related mortality. Here we show that metformin affects engraftment and growth of breast cancer tumours in mice. This correlates with the induction of metabolic changes compatible with clear anticancer effects. We demonstrate that microRNA modulation underlies the anticancer metabolic actions of metformin. In fact, metformin induces DICER expression and its effects are severely impaired in DICER knocked down cells. Conversely, ectopic expression of DICER recapitulates the effects of metformin in vivo and in vitro. The microRNAs upregulated by metformin belong mainly to energy metabolism pathways. Among the messenger RNAs downregulated by metformin, we found c-MYC, IRS-2 and HIF1alpha. Downregulation of c-MYC requires AMP-activated protein kinase-signalling and mir33a upregulation by metformin. Ectopic expression of c-MYC attenuates the anticancer metabolic effects of metformin. We suggest that DICER modulation, mir33a upregulation and c-MYC targeting have an important role in the anticancer metabolic effects of metformin.

[1]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[2]  G. P. Wheeler,et al.  Searches for exploitable biochemical differences between normal and cancer cells. VIII. Catabolism of purines and purine nucleotides by sonicates. , 1961, Cancer research.

[3]  H. Morris,et al.  Searches for exploitable biochemical differences between normal and cancer cells. IX. Anabolism and catabolism of purines by hepatomas 5123 and H-35. , 1962, Cancer research.

[4]  J. Zierath,et al.  Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. , 1991, Diabete & metabolisme.

[5]  K. Papas,et al.  Change in lactate production in Myc‐transformed cells precedes apoptosis and can be inhibited by Bcl‐2 overexpression , 1999, FEBS letters.

[6]  K. Hahn,et al.  Characterization of Morphological and Cytoskeletal Changes in MCF10A Breast Epithelial Cells Plated on Laminin-5: Comparison with Breast Cancer Cell Line MCF7 , 2001, Cell communication & adhesion.

[7]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[8]  Olle Ljunqvist,et al.  Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.

[9]  D. Hardie,et al.  The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. , 2002, Diabetes.

[10]  Huasheng Lu,et al.  Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.

[11]  E. Eigenbrodt,et al.  The tumor metabolome. , 2003, Anticancer research.

[12]  Julian L. Griffin,et al.  Metabolic profiles of cancer cells , 2004, Nature Reviews Cancer.

[13]  Marshall McLuhan,et al.  The medium is the message , 2005 .

[14]  R. Gillies,et al.  Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. , 2005, Neoplasia.

[15]  S. Ethier.  Human breast cancer cell lines as models of growth regulation and disease progression , 2005, Journal of Mammary Gland Biology and Neoplasia.

[16]  D. Kell,et al.  Metabolic footprinting and systems biology: the medium is the message , 2005, Nature Reviews Microbiology.

[17]  S. Canevari,et al.  Alterations of choline phospholipid metabolism in ovarian tumor progression. , 2005, Cancer research.

[18]  R. Gillies,et al.  Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors , 2005 .

[19]  Shuta Tomida,et al.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.

[20]  Russell G. Jones,et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.

[21]  V. Kim.  MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.

[22]  Ellen Ackerstaff,et al.  Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. , 2006, Molecular pharmaceutics.

[23]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[24]  Frank H. P. Fitzek,et al.  The Medium is the Message , 2006, 2006 IEEE International Conference on Communications.

[25]  S. Byron,et al.  Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells , 2006, British Journal of Cancer.

[26]  N. Sonenberg,et al.  Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. , 2007, Cancer research.

[27]  B. Viollet,et al.  Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. , 2007, Cancer research.

[28]  E. Bae,et al.  Metformin Prevents an Adaptive Increase in GSH and Induces Apoptosis Under the Conditions of GSH Deficiency in H4IIE Cells , 2007, Journal of toxicology and environmental health. Part A.

[29]  C. Thompson,et al.  HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. , 2007, Cancer cell.

[30]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.

[31]  Jan-Fang Cheng,et al.  Dicer, Drosha, and outcomes in patients with ovarian cancer. , 2008, The New England journal of medicine.

[32]  U. Edlund,et al.  Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.

[33]  M.-H. Lee,et al.  Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer , 2008, Cellular and Molecular Life Sciences.

[34]  J. Lindon,et al.  Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. , 2008, Annual review of analytical chemistry.

[35]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[36]  Mark R Viant,et al.  Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. , 2008, Analytical biochemistry.

[37]  Metformin, diet and breast cancer: An avenue for chemoprevention , 2009, Cell cycle.

[38]  A. Thor,et al.  Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro , 2009, Cell cycle.

[39]  C. Dang,et al.  MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.

[40]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[41]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[42]  Kevin Struhl,et al.  Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. , 2011, Cancer research.

[43]  G. Blandino,et al.  PGC1α confers specificity-metabolic stress and p53-dependent transcription. , 2011, Molecular cell.

[44]  K. Moore,et al.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling , 2011, Proceedings of the National Academy of Sciences.

[45]  Shailendra Giri,et al.  Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner , 2009, Journal of cellular and molecular medicine.

[46]  B. Viollet,et al.  AMP-activated protein kinase and metabolic control. , 2011, Handbook of experimental pharmacology.

[47]  S. Tokuyama,et al.  [Effectiveness of metformin in prevention of development of hyperglycemia and neuronal damage caused by ischemic stress]. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[48]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[49]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.